• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial.用于预防南部非洲女性感染艾滋病毒的隔膜和润滑剂凝胶:一项随机对照试验。
Lancet. 2007 Jul 21;370(9583):251-261. doi: 10.1016/S0140-6736(07)60950-7.
2
The use of the diaphragm instead of condoms in a phase III diaphragm trial.在一项三期子宫帽试验中使用子宫帽而非避孕套。
AIDS Behav. 2009 Jun;13(3):564-72. doi: 10.1007/s10461-008-9504-z. Epub 2008 Dec 16.
3
Effect of diaphragm and lubricant gel provision on human papillomavirus infection among women provided with condoms: a randomized controlled trial.向女性提供避孕套时同时提供隔膜和润滑剂凝胶对人乳头瘤病毒感染的影响:一项随机对照试验。
Obstet Gynecol. 2008 Nov;112(5):990-7. doi: 10.1097/AOG.0b013e318189a8a4.
4
Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial.卡拉胶预防南非女性感染艾滋病毒的疗效:一项随机、双盲、安慰剂对照试验。
Lancet. 2008 Dec 6;372(9654):1977-87. doi: 10.1016/S0140-6736(08)61842-5.
5
The diaphragm and lubricant gel for prevention of cervical sexually transmitted infections: results of a randomized controlled trial.用于预防宫颈性传播感染的隔膜与润滑剂凝胶:一项随机对照试验的结果
PLoS One. 2008;3(10):e3488. doi: 10.1371/journal.pone.0003488. Epub 2008 Oct 22.
6
Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial.替诺福韦 1%阴道凝胶预防南非妇女感染 HIV-1(FACTS-001):一项 3 期、随机、双盲、安慰剂对照试验。
Lancet Infect Dis. 2018 Nov;18(11):1241-1250. doi: 10.1016/S1473-3099(18)30428-6. Epub 2018 Oct 24.
7
Acceptability and use of the diaphragm and Replens lubricant gel for HIV prevention in Southern Africa.在南非,接受度和使用情况 (包括) 避孕膜和 Replens 润滑剂凝胶用于 HIV 预防。
AIDS Behav. 2010 Jun;14(3):629-38. doi: 10.1007/s10461-009-9609-z. Epub 2009 Sep 10.
8
PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial.PRO2000 阴道凝胶预防 HIV-1 感染(杀微生物剂开发计划 301):一项 3 期、随机、双盲、平行组试验。
Lancet. 2010 Oct 16;376(9749):1329-37. doi: 10.1016/S0140-6736(10)61086-0. Epub 2010 Sep 17.
9
User experiences and acceptability attributes of the diaphragm and lubricant gel in an HIV prevention trial in southern Africa.在南部非洲进行的一项艾滋病预防试验中,子宫帽和润滑剂凝胶的用户体验及可接受性特征。
AIDS Care. 2011 Aug;23(8):1026-34. doi: 10.1080/09540121.2010.543879.
10
Predictors of diaphragm use as a potential sexually transmitted disease/HIV prevention method in Zimbabwe.津巴布韦将使用隔膜作为一种潜在的性传播疾病/艾滋病预防方法的预测因素。
Sex Transm Dis. 2005 Jan;32(1):64-71. doi: 10.1097/01.olq.0000148301.90343.3a.

引用本文的文献

1
Review of Impact of Risk Reduction Sessions on Sexual Behaviors in HIV Prevention Trials: Insights from Africa.艾滋病预防试验中降低风险课程对性行为影响的综述:来自非洲的见解
Arch Sex Behav. 2025 Feb;54(2):805-815. doi: 10.1007/s10508-024-03052-8. Epub 2025 Jan 13.
2
Statistical methods in the analysis of multicentre HIV randomized controlled trials in the African region: a scoping review.非洲地区多中心HIV随机对照试验分析中的统计方法:一项范围综述
BMC Med Res Methodol. 2025 Jan 8;25(1):3. doi: 10.1186/s12874-024-02441-w.
3
Learnings From an Innovative Model to Expand Access to a New and Underutilized Nonhormonal Contraceptive Diaphragm.创新模式扩大新型和未充分利用的非激素避孕隔膜的获取途径的经验教训。
Glob Health Sci Pract. 2024 Oct 29;12(5). doi: 10.9745/GHSP-D-24-00215.
4
Reproductive health needs of HIV serodiscordant couples: a systematic review.HIV 血清不一致夫妇的生殖健康需求:系统评价。
Front Public Health. 2024 Aug 29;12:1348026. doi: 10.3389/fpubh.2024.1348026. eCollection 2024.
5
Meta-analysis of Pregnancy Events in Biomedical HIV Prevention Trials in Sub-Saharan Africa: Implications for Gender Transformative Trials.撒哈拉以南非洲地区生物医学 HIV 预防试验中的妊娠事件的荟萃分析:对性别转化试验的启示。
AIDS Behav. 2024 Nov;28(11):3850-3872. doi: 10.1007/s10461-024-04459-z. Epub 2024 Aug 17.
6
Spatial variations in STIs among women enrolled in HIV prevention clinical trials in Durban, KwaZulu-Natal, South Africa.南非夸祖鲁-纳塔尔省德班的 HIV 预防临床试验中,女性性传播感染的空间差异。
SAHARA J. 2023 Dec;20(1):2193238. doi: 10.1080/17290376.2023.2193238.
7
The initial interplay between HIV and mucosal innate immunity.HIV 与黏膜固有免疫的初始相互作用。
Front Immunol. 2023 Jan 30;14:1104423. doi: 10.3389/fimmu.2023.1104423. eCollection 2023.
8
Estimating prevalence and incidence of sexually transmitted infections among South African women: Implications of combined impacts of risk factors.估算南非女性性传播感染的患病率和发病率:风险因素综合影响的意义
Int J STD AIDS. 2020 Oct;31(11):1093-1101. doi: 10.1177/0956462420915388. Epub 2020 Sep 3.
9
Temporal trends in sexual behaviours and their impacts on HIV incidence among South African women: 2002-2016.南非女性性行为的时间趋势及其对艾滋病毒感染率的影响:2002-2016 年。
AIDS Care. 2021 Aug;33(8):1002-1008. doi: 10.1080/09540121.2020.1789054. Epub 2020 Jul 23.
10
Contraceptives and sexual behaviours in predicting pregnancy rates in HIV prevention trials in South Africa: Past, present and future implications.避孕措施和性行为在预测南非艾滋病预防试验中的妊娠率方面的作用:过去、现在和未来的影响。
Sex Reprod Healthc. 2020 Dec;26:100531. doi: 10.1016/j.srhc.2020.100531. Epub 2020 May 18.

本文引用的文献

1
Sexual behavior and STI/HIV status among adolescents in rural Malawi: an evaluation of the effect of interview mode on reporting.马拉维农村地区青少年的性行为及性传播感染/艾滋病毒状况:访谈方式对报告结果影响的评估
Stud Fam Plann. 2008 Dec;39(4):321-34. doi: 10.1111/j.1728-4465.2008.00178.x.
2
Scientists rethink approach to HIV gels.科学家重新思考艾滋病病毒凝胶的研究方法。
Nature. 2007 Mar 1;446(7131):12. doi: 10.1038/446012a.
3
Trial and failure.尝试与失败。
Nature. 2007 Mar 1;446(7131):1. doi: 10.1038/446001a.
4
Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial.乌干达拉凯地区男性包皮环切术预防男性感染艾滋病毒的随机试验。
Lancet. 2007 Feb 24;369(9562):657-66. doi: 10.1016/S0140-6736(07)60313-4.
5
Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial.肯尼亚基苏木年轻男性包皮环切术预防艾滋病病毒感染的随机对照试验。
Lancet. 2007 Feb 24;369(9562):643-56. doi: 10.1016/S0140-6736(07)60312-2.
6
Audio computer-assisted self-interviewing in reproductive health research: reliability assessment among women in Harare, Zimbabwe.生殖健康研究中的音频计算机辅助自我访谈:津巴布韦哈拉雷女性的可靠性评估
Contraception. 2007 Jan;75(1):59-65. doi: 10.1016/j.contraception.2006.07.002. Epub 2006 Sep 18.
7
The importance of discreet use of the diaphragm to Zimbabwean women and their partners.谨慎使用子宫托对津巴布韦女性及其伴侣的重要性。
AIDS Behav. 2007 May;11(3):443-51. doi: 10.1007/s10461-006-9190-7. Epub 2006 Dec 8.
8
Prostate-specific antigen to ascertain reliability of self-reported coital exposure to semen.使用前列腺特异性抗原确定自我报告的性交时接触精液情况的可靠性。
Sex Transm Dis. 2006 Aug;33(8):476-9. doi: 10.1097/01.olq.0000231960.92850.75.
9
Acceptability and feasibility of continuous diaphragm use among sex workers in Madagascar.马达加斯加性工作者持续使用子宫托的可接受性与可行性
Sex Transm Infect. 2005 Dec;81(6):472-6. doi: 10.1136/sti.2005.015107.
10
Barrier method preferences and perceptions among Zimbabwean women and their partners.津巴布韦女性及其伴侣对屏障避孕法的偏好与认知
AIDS Behav. 2005 Dec;9(4):415-22. doi: 10.1007/s10461-005-9013-2.

用于预防南部非洲女性感染艾滋病毒的隔膜和润滑剂凝胶:一项随机对照试验。

Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial.

作者信息

Padian Nancy S, van der Straten Ariane, Ramjee Gita, Chipato Tsungai, de Bruyn Guy, Blanchard Kelly, Shiboski Stephen, Montgomery Elizabeth T, Fancher Heidi, Cheng Helen, Rosenblum Michael, van der Laan Mark, Jewell Nicholas, McIntyre James

机构信息

University of California, San Francisco, CA, USA.

University of California, San Francisco, CA, USA.

出版信息

Lancet. 2007 Jul 21;370(9583):251-261. doi: 10.1016/S0140-6736(07)60950-7.

DOI:10.1016/S0140-6736(07)60950-7
PMID:17631387
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2442038/
Abstract

BACKGROUND

Female-controlled methods of HIV prevention are urgently needed. We assessed the effect of provision of latex diaphragm, lubricant gel, and condoms (intervention), compared with condoms alone (control) on HIV seroincidence in women in South Africa and Zimbabwe.

METHODS

We did an open-label, randomised controlled trial in HIV-negative, sexually active women recruited from clinics and community-based organisations, who were followed up quarterly for 12-24 months (median 21 months). All participants received an HIV prevention package consisting of pre-test and post-test counselling about HIV and sexually transmitted infections, testing, treatment of curable sexually transmitted infections, and intensive risk-reduction counselling. The primary outcome was incident HIV infection. This study is registered with ClinicalTrials.gov, number NCT00121459.

FINDINGS

Overall HIV incidence was 4.0% per 100 woman-years: 4.1% in the intervention group (n=2472) and 3.9% in the control group (n=2476), corresponding to a relative hazard of 1.05 (95% CI 0.84-1.32, intention-to-treat analysis). The proportion of women using condoms was significantly lower in the intervention than in the control group (54%vs 85% of visits, p<0.0001). The proportions of participants who reported adverse events (60% [1523] vs 61% [1529]) and serious adverse events (5% [130] vs 4% [101]) were similar between the two groups.

INTERPRETATION

We observed no added protective benefit against HIV infection when the diaphragm and lubricant gel were provided in addition to condoms and a comprehensive HIV prevention package. Our observation that lower condom use in women provided with diaphragms did not result in increased infection merits further research. Although the intervention seemed safe, our findings do not support addition of the diaphragm to current HIV prevention strategies.

摘要

背景

迫切需要女性主导的艾滋病预防方法。我们评估了提供乳胶隔膜、润滑剂凝胶和避孕套(干预组)与仅提供避孕套(对照组)相比,对南非和津巴布韦女性艾滋病血清感染率的影响。

方法

我们在从诊所和社区组织招募的HIV阴性、有性行为的女性中进行了一项开放标签的随机对照试验,对她们每季度随访12 - 24个月(中位数为21个月)。所有参与者都接受了一个艾滋病预防套餐,包括关于艾滋病和性传播感染的检测前和检测后咨询、检测、可治愈性传播感染的治疗以及强化的风险降低咨询。主要结局是新发艾滋病感染。本研究已在ClinicalTrials.gov注册,注册号为NCT00121459。

结果

总体艾滋病发病率为每100女性年4.0%:干预组(n = 2472)为4.1%,对照组(n = 2476)为3.9%,意向性分析得出相对风险为1.05(95%可信区间0.84 - 1.32)。干预组使用避孕套的女性比例显著低于对照组(就诊时分别为54%和85%,p < 0.0001)。两组报告不良事件的参与者比例(60% [1523]对61% [1529])和严重不良事件的比例(5% [130]对4% [101])相似。

解读

除了避孕套和全面的艾滋病预防套餐外,再提供隔膜和润滑剂凝胶时,我们未观察到对艾滋病感染有额外的保护益处。我们观察到,配备隔膜的女性中避孕套使用率较低,但并未导致感染增加,这一现象值得进一步研究。尽管干预措施似乎是安全的,但我们的研究结果不支持在当前的艾滋病预防策略中增加隔膜。